Star Bio Pharma Global strengthens its position in the global nutraceutical supply Chain

Star Bio Pharma Global Pvt. Ltd., a rapidly growing pharmaceutical and nutraceutical ingredients manufacturer, has further strengthened its position in India’s specialty ingredients sector by emerging as the country’s leading exporter of high-purity vitamin K2 (2000 PPM). Vitamin K2 has gained significant attention in preventive healthcare owing to its role in supporting bone health, cardiovascular wellness, and calcium metabolism, making it one of the fastest-growing specialty ingredients in the nutraceutical industry.

In addition to Vitamin K2, Star Bio Pharma Global has built strong manufacturing capabilities in Curcumin and Piperine, two plant-derived bioactive ingredients extensively used in pharmaceuticals, nutraceuticals, functional foods, and wellness formulations.

Backed by advanced manufacturing infrastructure in Bengaluru, stringent quality systems, and internationally accepted manufacturing standards, Star Bio Pharma Global has steadily expanded its presence across domestic and export markets. The company focuses on delivering high-potency ingredients with consistent purity, traceability, and regulatory compliance to meet the evolving requirements of global formulation companies.

Pramod Chandra, director, Star Bio Pharma Global Pvt. Ltd., said: “Becoming one of India’s leading exporters of high-purity vitamin K2 (2000 PPM) reflects our commitment to manufacturing products that meet global expectations. Alongside vitamin K2, our capabilities in Curcumin, Piperine, and the supply of Caffeine Anhydrous enable us to support pharmaceutical and nutraceutical companies with reliable, premium-quality ingredients. Our focus remains on expanding India’s manufacturing capabilities while strengthening our global footprint.”

Pooja Ravindra Rokade, director, Star Bio Pharma Global, said: “Our journey has been driven by continuous investment in technology, quality systems, research, and customer trust. We understand that today’s healthcare and nutraceutical industries demand ingredients that are not only effective but also manufactured with complete quality assurance and regulatory compliance. As we continue to scale our operations, we remain committed to building long-term partnerships with customers across India and international markets while contributing to the ‘Make in India’ vision for specialty pharmaceutical and nutraceutical ingredients.”

Related Posts

Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says

US President Donald Trump on Monday said nine pharmaceutical manufacturers, including Sun Pharma, have reached agreements with his administration to lower prescription drug prices for Americans in line with the…

FIR against 22 foreign medical graduates for uploading fake docus on Maharashtra Medical Council portal to obtain temporary registration without clearing screening test

Mumbai: The Maharashtra Nodal Cyber Police have registered an FIR against 22 foreign medical graduates for allegedly uploading fake and suspicious documents on Maharashtra Medical Council (MMC) portal to obtain…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says

Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says

FIR against 22 foreign medical graduates for uploading fake docus on Maharashtra Medical Council portal to obtain temporary registration without clearing screening test

FIR against 22 foreign medical graduates for uploading fake docus on Maharashtra Medical Council portal to obtain temporary registration without clearing screening test

FUJIFILM India is zeroing in on Indian Gut with Advanced Therapeutic Endoscopy

FUJIFILM India is zeroing in on Indian Gut with Advanced Therapeutic Endoscopy

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government